Sorana Segal-Maurer, MD

Division of Infectious Diseases, New York–Presbyterian Queens

Disclosure(s): Gilead Sciences, Inc.: Advisor/Consultant, Grant/Research Support, Honoraria; Janssen: Advisor/Consultant; Theratechnologies: Advisor/Consultant; ViiV: Advisor/Consultant

Poster(s):

• (P-481) Characterization of People with HIV Who Are Virologically Suppressed with Treatment Experience Using a US Real-World Database
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT